Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt

Anne Troldborg; Trine Bay-Laurberg; Kåre Clemmensen; Jeanette Andersen; Bent Deleuran

Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt

Translated title of the contribution: Hydroxychloroquine treatment rarely causes eye damage when used correctly

Anne Troldborg, Trine Bay-Laurberg, Kåre Clemmensen, Jeanette Andersen, Bent Deleuran

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

Abstract

Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction. In this review, we wish to emphasise "best practice" in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.

Translated title of the contribution	Hydroxychloroquine treatment rarely causes eye damage when used correctly
Original language	Danish
Journal	Ugeskrift for Læger
Volume	182
Issue	32
ISSN	0041-5782
Publication status	Published - 3 Aug 2020

Cite this

@article{6dfc6d57c62247d9a82bc0a5dcc2c075,

title = "Hydroxychlorokin behandling for{\aa}rsager sj{\ae}ldent {\o}jenskader n{\aa}r det anvendes korrekt",

abstract = "Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction. In this review, we wish to emphasise {"}best practice{"} in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.",

keywords = "Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, Female, Humans, Hydroxychloroquine/adverse effects, Lupus Erythematosus, Systemic/drug therapy, Pregnancy, Retinal Diseases/prevention & control",

author = "Anne Troldborg and Trine Bay-Laurberg and K{\aa}re Clemmensen and Jeanette Andersen and Bent Deleuran",

year = "2020",

month = aug,

day = "3",

language = "Dansk",

volume = "182",

journal = "Ugeskrift for L{\ae}ger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "32",

}

TY - JOUR

T1 - Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt

AU - Troldborg, Anne

AU - Bay-Laurberg, Trine

AU - Clemmensen, Kåre

AU - Andersen, Jeanette

AU - Deleuran, Bent

PY - 2020/8/3

Y1 - 2020/8/3

N2 - Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction. In this review, we wish to emphasise "best practice" in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.

AB - Hydroxychloroquine (HCQ) is used in the treatment of rheumatologic diseases including systemic lupus erythematosus, rheumatoid arthritis and other conditions. Besides reducing joint and skin inflammation, growing evidence shows other beneficial effects of HCQ, e.g. a positive effect on cardiovascular risk, pregnancy outcome, and flare reduction. In this review, we wish to emphasise "best practice" in the use of HCQ based on the present literature, to show the typical eye damage, which may occur, and to highlight which precautions should be made, so that retinal injury does not occur.

KW - Antirheumatic Agents/therapeutic use

KW - Arthritis, Rheumatoid/drug therapy

KW - Female

KW - Humans

KW - Hydroxychloroquine/adverse effects

KW - Lupus Erythematosus, Systemic/drug therapy

KW - Pregnancy

KW - Retinal Diseases/prevention & control

M3 - Review

C2 - 32800050

SN - 0041-5782

VL - 182

JO - Ugeskrift for Læger

JF - Ugeskrift for Læger

IS - 32

ER -

Hydroxychlorokin behandling forårsager sjældent øjenskader når det anvendes korrekt

Abstract

Fingerprint

Cite this